Global Allergy Diagnostics Market (2025 Edition): Analysis By Test Type (In Vivo, In Vitro, Accessories), By Product and Services, By Region, By Country: Market Insights and Forecast (2021-2031)

Executive Summary

Azoth Analytics has released a research report titled “Global Allergy Diagnostics Market (2025 Edition)” which provides a complete analysis of the Global Allergy Diagnostics industry in terms of market segmentation By Test Type (In Vivo, In Vitro), By Product and Services (Consumables, Instruments, Services) for the historical period of 2021-2024, the estimates of 2025 and the forecast period of 2026-2031.

The report analyses the Allergy Diagnostics Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India). The Global Allergy Diagnostics market showcased growth at a CAGR of 10.10% during 2021-2024. The market was valued at USD 6033.25 Million in 2024 which is expected to reach USD 12547.88 Million in 2031.

The global allergy diagnostics market is experiencing significant growth, driven by the rising incidence of allergic disorders worldwide. According to the World Allergy Organization (WAO), allergies affect nearly 30–40% of the global population, with an increasing trend due to environmental and lifestyle changes.

Allergic reactions range from mild symptoms, such as sneezing and rashes, to severe, life-threatening conditions like anaphylaxis and asthma exacerbations. As a result, there is a growing demand for precise and early diagnostic solutions to improve patient outcomes.

Air pollution, pollen count fluctuations, and climate change have led to a surge in allergic conditions, particularly asthma and allergic rhinitis. According to the WHO, approximately 300 million people worldwide suffer from asthma, many of whom have allergy-induced symptoms.

The field of allergy diagnostics is witnessing rapid technological advancements, significantly improving the accuracy, efficiency, and accessibility of testing methods. For instance, Multiplex assays have revolutionized the market by enabling the simultaneous detection of multiple allergens in a single test. These high-throughput assays not only reduce the time required for diagnosis but also improve cost efficiency by consolidating tests that traditionally required multiple separate analyses.

Scope of the Report:

• The report analyses the Allergy Diagnostics Market by Value (USD Million).
• The report presents the analysis of Allergy Diagnostics Market for the historical period of 2021-2024, the estimated year 2025 and the forecast period of 2026-2031.
• The report analyses the Allergy Diagnostics Market By Test Type (In Vivo, In Vitro)
• The report analyses the Allergy Diagnostics Market By Product and Services (Consumables, Instruments, Services).
• The key insights of the report have been presented through the frameworks of SWOT and Porter’s Five Forces Analysis. Also, the attractiveness of the market has been presented by region, By Test Type, and By Product and Services.
• Also, the major opportunities, trends, drivers, and challenges of the industry has been analyzed in the report.
• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Thermo Fisher Scientific, Becton, Dickinson and Company, Danaher Corporation, Siemens Healthineers, Lincoln Diagnostics, Inc., HYCOR Biomedical, Abionic SA, Curex, Stallergenes Greer Ltd, HAL Allergy Group